BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

1 Deoxynojirimycin

An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity.

299+ PubMed studies analyzed · 4 RCTs · Evidence Score: 42.1

Research Domains

1 Deoxynojirimycin has been studied across 20 research domains including 🔥 Metabolic, 🫁 Liver & Detox, 🧬 Hormones, 🦠 Gut & Microbiome, 🔬 Oncology. The primary research focus is 🔥 Metabolic with 27% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with 1 Deoxynojirimycin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

miglitol
4 shared targets
duvoglustat
6 shared targets
miglustat
4 shared targets
migalastat
4 shared targets
salacinol
2 shared targets
voglibose
2 shared targets
amlexanox
2 shared targets
Genistein
2 shared targets
Quercetin
4 shared targets
Luteolin
2 shared targets
Loading evidence profile...

This evidence profile for 1 Deoxynojirimycin is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.